BNIP3 is closely related to the malignancy of tumors; its expression level is significantly higher in breast ductal carcinoma in situ and invasive breast cancer than in normal breast tissue, and its expression level in lobular invasive lung cancer is substantially higher than that in ductal carcinoma in situ. This evidence concerns the gene BNIP3 and invasive breast carcinoma.